Comparison of the difference between Amaryl and Forxiga tablets for the treatment of Type 2 diabetes

Comparison of the difference between Amaryl and Forxiga tablets for the treatment of Type 2 diabetes
Comparison of the difference between Amaryl and Forxiga tablets for the treatment of Type 2 diabetes


Article Content:

    Both Amaryl and Forxiga are used to treat type 2 diabetes, but they belong to two different classes of medications that work by different mechanisms to lower blood sugar levels. Understanding these differences is crucial for effective diabetes management.

    Amaryl Tablets Ingredients

    Amaryl tablets contain the active ingredient glimepiride. Glimepiride is a sulfonylurea that works by stimulating the beta cells in the pancreas to secrete more insulin. It is a drug that increases insulin production in the body.

    Forxiga Tablets Ingredients

    Forxiga tablets contain the active ingredient dapagliflozin. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by preventing glucose reabsorption in the kidneys, resulting in more glucose being excreted in the urine and thus lowering blood sugar levels. It may also provide additional benefits for the heart and kidneys.

    Information about Amaryl tablets

    Drug class: Sulfonylureas

    Drug classification: Third-generation sulfonylureas

    Pharmaceutical form: Tablets

    Pharmaceutical family: Diabetes medications

    Active ingredient: Glimepiride

    Information about Forxiga tablets

    Drug class: SGLT2 inhibitors

    Drug class: Phenylglycoside

    Pharmaceutical form: Coated tablets

    Pharmaceutical family: Diabetes medications

    Active ingredient: Dapagliflozin


    Dr. Rawan Mossad Elsaed
    Scientific Degree: Pharmacist
    Country: Egypt
    Dr. Rawan Mosaad El-Saeed is a clinical pharmacist and medical content reviewer holding a Bachelor of Pharmacy degree from Horus University in Egypt. She has hands-on community pharmacy experience in providing medication therapy counseling, monitoring drug-drug interactions, and ensuring patient adherence to safe usage protocols. She specializes in authoring and fact-checking pharmaceutical guides and simplifying clinical pharmacology based on the latest evidence-based guidelines and internationally accredited references, dedicated to delivering accurate, reliable, and safe healthcare information for readers.
    Published Date: 23 April 2025

    Source 1 : Drugs Glimepiride Source 2 : Drugs Dapagliflozin
    you should ask your doctor before taking this medicine